The largest database of trusted experimental protocols

Verteporfin

Manufactured by Avantor
Sourced in United States

Verteporfin is a photosensitizing agent used in photodynamic therapy. It is a powder that is reconstituted and administered intravenously. Verteporfin accumulates in rapidly dividing cells and can be activated by light, leading to the generation of reactive oxygen species that damage the target cells.

Automatically generated - may contain errors

13 protocols using verteporfin

1

Photosensitizer Verteporfin Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin, Visudyne) was purchased from VWR (Cat No 1711461). Solutions were prepared in DMSO. Cyclosporin A (CsA) and other reagents were obtained from Sigma-Aldrich and Calbiochem Corp. and were of the highest available purity.
+ Open protocol
+ Expand
2

Verteporfin-Mediated Photodynamic Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin) was purchased from VWR (Cat No 1711461), Radnor PA. The phenothiazine 5-ethylamino-9- diethyl-aminobenzo [a]phenothiazinium chloride (EtNBS) was provided by Dr. Conor Evans, Wellman Labs, Massachusetts General Hospital/Harvard Medical School. Its preparation has been described [13 ]. Fluorescent probes were purchased from Thermo Fisher Scientific, Waltham MA. Other reagents were obtained from MilliporeSigma, St. Louis MO.
+ Open protocol
+ Expand
3

Verteporfin-Based Photodynamic Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin) was purchased from VWR (Cat No 1711461). Other reagents were obtained from Sigma-Aldrich and were of the highest available purity. Fluorescent probes were provided by Life Technologies/Molecular Probes/Invitrogen, Carlsbad, CA.
+ Open protocol
+ Expand
4

Fluorescent Probe Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
NPe6 was provided by Dr. Kevin M. Smith, Louisiana State University. BPD (benzoporphyrin derivative, Verteporfin) was purchased from VWR (Cat No 1711461). Other reagents were obtained from Sigma-Aldrich and were of the highest available purity. Fluorescent probes were provided by Life Technologies, Inc.. Diethyl-3-3′-(9,10-anthracenediyl)bis acrylate (DADB) was prepared and utilized as previously reported (16 (link)). Synthesis of the fluorescent probe RhoNox-1 (RN-1) was carried out as described in reference 17 . RN-1 is a non fluorescent N-oxide of Rhodamine B that is converted to a fluorescent product upon contact with Fe++.
+ Open protocol
+ Expand
5

Photodynamic Therapy Reagents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
NPe6 was provided by Dr. Kevin M. Smith, Louisiana State University. BPD
(benzoporphyrin derivative, Verteporfin) was purchased from VWR (Cat No 1711461). EtBNS
was prepared as described by Clapp et al (7 ) and
provided by Dr. Conor Evans (Harvard Medical School\Massachusetts General
Hospital). The galactose conjugate of 3-(1-hexyloxyethyl)-3-devinyl
pyropeophorbide-a (HPPHgal) was provided by Dr. R.K. Pandey, Roswell
Park Cancer Institute (8 (link)). Other reagents were
obtained from Sigma-Aldrich and were of the highest available purity. Fluorescent probes
were provided by Life Technologies, Inc.
+ Open protocol
+ Expand
6

Photosensitizer-Guided Cancer Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin) was obtained from VWR (Cat No 1711461), Radnor PA. NPe6 was provided by Prof. Kevin M. Smith, Louisiana State University. Fluorescent probes were provided by Thermo Fisher Scientific. Other reagents were obtained from Sigma-Aldrich or Calbiochem Corp. and were of the highest available purity.
+ Open protocol
+ Expand
7

Mouse Model for Ovarian Cancer Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo comparisons we used a murine model of disseminated ovarian carcinoma previously established in our laboratory38 (link). Briefly, female Swiss nude mice (Cox, Cambridge, MA), 6–8 weeks old, were injected intraperitoneally 3.15 × 107 OVCAR5 cells in single cell suspension in 2 mL PBS. Tumours were allowed to develop for 14 days prior to imaging, during which time mice had continual access to food and water while being housed in laminar flow racks under specific pathogen-free conditions. Microendoscopy was performed as previously described39 (link), using intraperitoneal injection with 1 mg/kg body weight of verteporfin (benzoporhyrin derivative monoacid ring-A or BPD-MA, VWR, Radnor, PA, USA) for fluorescence contrast. Imaging was performed under anesthesia with the fibre probe introduced into the intraperitoneal cavity via a catheter inserted through the abdominal wall. Approximately 20 separate microendoscope fields were obtained throughout the peritoneal cavity for each mouse. Microendoscope images were segmented in the same manner as described below for 3D cell cultures to obtain the distribution of tumour sizes throughout the peritoneal cavity. All animal procedures were conducted in accordance with institutional guidelines for research animal care.
+ Open protocol
+ Expand
8

Viability of Bile Duct Cells Treated with Verteporfin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture was performed using the human SV-40 immortalized, non-malignant intrahepatic bile duct cell line, H69 (a gift from Dr. Nicholas LaRusso, Mayo Clinic, Rochester, MN and Dr. Douglas Jefferson, Tufts University, Boston, MA) originally isolated from a normal liver prior to transplantation and cultured as previously described22 (link). HuCCT1 cholangiocarcinoma cell line was a kind gift of Dr. Anthony J Demetris (University of Pittsburgh). Cells were plated in 96 well plates at a density of 2,500 cells/well and assessed for viability prior to experimentation. Verteporfin (VWR Radnor PA, USA) or vehicle control was added at day 0, for 24, 48 or 72 hours, at concentrations of 0μM, 1.25 μM, 2.5 μM and 5 μM. The number and cell viability were assessed by Vybrant® MTT Cell Proliferation Assay Kit (Invitrogen, Carlsbad, CA), per manufacturer’s instructions and assessed using SPECTRAMAX 340PC spectrophotometer (Molecular Devices, Sunnyvale, CA USA).
+ Open protocol
+ Expand
9

Photosensitizer Reagents for PDT

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin) was provided by VWR (Cat No 1711461), Radnor PA. The chlorin NPe6, was obtained from Dr. Kevin M. Smith, Louisiana State University. Hypericin was purchased from BeanTown Chemical, Hudson NH. Photofrin was obtained from Pinnacle Biologics, Chicago IL. The pyropheophorbide HPPH was provided by Dr. R. Pandey, Roswell Park Cancer Institute; mTHPC was a gift from Prof. Ray Bonnett, Queen Mary College, London. Photofrin was generously provided by Pinnacle Biologics Inc. Other reagents were obtained from Sigma-Aldrich or Calbiochem Corp. and were of the highest available purity. Fluorescent probes used in this study were purchased from Thermo Fisher Scientific and Enzo Life Sciences, Farmingdale NY.
+ Open protocol
+ Expand
10

Verteporfin-Based Photodynamic Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPD (benzoporphyrin derivative, Verteporfin) was purchased from VWR (Cat No 1711461), Radnor PA. NPe6 was provided by Prof. Kevin M. Smith, Department of Chemistry, Louisiana State University. Fluorescent probes were purchased from Thermo Fisher Scientific, Waltham MA. Other reagents were obtained from MilliporeSigma, St. Louis MO.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!